Nasdaq or NYSE related Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of August 2026
Nasdaq or NYSE listed Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of August 2026. Nasdaq and NYSE related Biotechnology: Pharmaceutical Preparations industry Largest Companies List by Market Cap as of August 2026
-
World Rank (Aug-2026)4,693Market Cap (Aug-2026)3.373 Billion USDWorld Rank (Jan-05-2024)15,314Market Cap (Jan-05-2024)0.324 Billion USDWorld Rank (Jul-30-2023)13,144Market Cap (Jul-30-2023)0.469 Billion USDWorld Rank (Dec-25-2022)7,966Market Cap (Dec-25-2022)1.090 Billion USDWorld Rank (Jan-07-2022)9,983Market Cap (Jan-07-2022)0.90 Billion USDAnnual Revenue in USD524 Million USDAnnual Net Income in USD329 Million USDAnnual Results for Period EndingDec-2021 ending yearCompany ProfileBiotechnology company with headquarters is in Amsterdam, Netherlands.Company Website
-
AbCellera Biologics Inc.
World Rank (Aug-2026)4,707Market Cap (Aug-2026)3.353 Billion USDWorld Rank (Jan-05-2024)6,216Market Cap (Jan-05-2024)1.724 Billion USDWorld Rank (Jul-30-2023)5,362Market Cap (Jul-30-2023)2.220 Billion USDWorld Rank (Dec-25-2022)4,125Market Cap (Dec-25-2022)2.955 Billion USDWorld Rank (Jan-07-2022)4,491Market Cap (Jan-07-2022)3.33 Billion USDAnnual Revenue in USD288 Million USDAnnual Net Income in USD118 Million USDAnnual Results for Period EndingDec-2021 ending yearCompany ProfileABCELLERA BIOLOGICS INC. is Biotechnology sector company with headquarters is in Vancouver, Canada.Company WebsiteWikipedia -
Arcutis Biotherapeutics Inc.
World Rank (Aug-2026)4,757Market Cap (Aug-2026)3.292 Billion USDWorld Rank (Jan-05-2024)14,287Market Cap (Jan-05-2024)0.381 Billion USDWorld Rank (Jul-30-2023)10,942Market Cap (Jul-30-2023)0.667 Billion USDWorld Rank (Dec-25-2022)9,104Market Cap (Dec-25-2022)0.871 Billion USDWorld Rank (Jan-07-2022)9,768Market Cap (Jan-07-2022)0.94 Billion USDAnnual Revenue in USD372 Million USDAnnual Net Income in USD-16 Million USDAnnual Results for Period EndingFor year ending December-2025Company ProfileArcutis Biotherapeutics is a Pioneering Medical Dermatology company dedicated to revolutionizing the treatment of serious skin diseases. It is focused on filling the innovation gap in medical dermatology drug development by applying deep clinical, product development and commercial expertise in dermatology to develop best in class therapies against biologically validated targets. It is having 29 employees as on 2019. The headquarters is in USA.Company Website -
NewAmsterdam Pharma Company N.V.
World Rank (Aug-2026)4,823Market Cap (Aug-2026)3.225 Billion USDWorld Rank (Jan-05-2024)8,641Market Cap (Jan-05-2024)0.989 Billion USDWorld Rank (Jul-30-2023)8,861Market Cap (Jul-30-2023)0.973 Billion USDWorld Rank (Dec-25-2022)8,503Market Cap (Dec-25-2022)0.973 Billion USDCompany Website -
Disc Medicine Inc.
World Rank (Aug-2026)5,015Market Cap (Aug-2026)3.027 Billion USDWorld Rank (Jan-05-2024)6,852Market Cap (Jan-05-2024)1.472 Billion USDWorld Rank (Jul-30-2023)8,317Market Cap (Jul-30-2023)1.089 Billion USDAnnual Net Income in USD-212 Million USDAnnual Results for Period EndingFor year ending December-2025Company Website -
Zai Lab
World Rank (Aug-2026)5,125Market Cap (Aug-2026)2.908 Billion USDWorld Rank (Jan-05-2024)4,807Market Cap (Jan-05-2024)2.622 Billion USDWorld Rank (Jul-30-2023)4,184Market Cap (Jul-30-2023)3.176 Billion USDWorld Rank (Dec-25-2022)4,923Market Cap (Dec-25-2022)2.320 Billion USDWorld Rank (Jan-07-2022)3,121Market Cap (Jan-07-2022)5.31 Billion USDAnnual Revenue in USD144 Million USDAnnual Net Income in USD-704 Million USDAnnual Results for Period EndingDec-2021 ending yearCompany ProfileZai Lab is an Innovative and Research Based Commercial Stage Biopharmaceutical company based in China and the U.S. focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world. It is having 900 employees as on 2020. The headquarters is in China.
Company Website -
Nurix Therapeutics Inc.
World Rank (Aug-2026)5,235Market Cap (Aug-2026)2.807 Billion USDWorld Rank (Jan-05-2024)12,883Market Cap (Jan-05-2024)0.478 Billion USDWorld Rank (Jul-30-2023)13,148Market Cap (Jul-30-2023)0.469 Billion USDWorld Rank (Dec-25-2022)12,559Market Cap (Dec-25-2022)0.489 Billion USDWorld Rank (Jan-07-2022)8,355Market Cap (Jan-07-2022)1.23 Billion USDAnnual Revenue in USD84 Million USDAnnual Net Income in USD-264 Million USDAnnual Results for Period EndingFor year ending November-2025Company ProfileNurix Therapeutics is a Biopharmaceutical company discovers drugs that harness the bodies natural process to control protein levels and drugs control ubiquitin E3 ligases, the key enzymes responsible for protein breakdown in human cells as a unique therapeutic approach to treat a broad range of diseases. The company annual revenue is 17.8 million USD and 103 employees as on 2019. The headquarters is in USA.Company Website -
Supernus Pharmaceuticals
World Rank (Aug-2026)5,237Market Cap (Aug-2026)2.806 Billion USDWorld Rank (Jan-05-2024)6,703Market Cap (Jan-05-2024)1.522 Billion USDWorld Rank (Jul-30-2023)6,453Market Cap (Jul-30-2023)1.657 Billion USDWorld Rank (Dec-25-2022)5,403Market Cap (Dec-25-2022)2.026 Billion USDWorld Rank (Jan-07-2022)7,241Market Cap (Jan-07-2022)1.58 Billion USDAnnual Revenue in USD719 Million USDAnnual Net Income in USD-39 Million USDAnnual Results for Period EndingFor year ending December-2025Company ProfileSupernus Pharmaceuticals is a pharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system diseases. The company annual revenue is 392.8 million USD and 464 employees as on 2019. The headquarters is in USA.Company Website -
ATAI Life Sciences N.V.
World Rank (Aug-2026)5,361Market Cap (Aug-2026)2.692 Billion USDWorld Rank (Jan-05-2024)16,036Market Cap (Jan-05-2024)0.286 Billion USDWorld Rank (Jul-30-2023)15,102Market Cap (Jul-30-2023)0.342 Billion USDWorld Rank (Dec-25-2022)13,197Market Cap (Dec-25-2022)0.443 Billion USDWorld Rank (Jan-07-2022)9,233Market Cap (Jan-07-2022)1.03 Billion USDCompany ProfileAtai is a biopharmaceutical company that leverages a decentralised platform approach to incubate and accelerate the development of highly effective mental health treatments that address the unmet needs of patients. Headquarters is in Germany.Company Website -
Trevi Therapeutics
World Rank (Aug-2026)5,440Market Cap (Aug-2026)2.630 Billion USDWorld Rank (Jan-05-2024)22,095Market Cap (Jan-05-2024)0.088 Billion USDWorld Rank (Jul-30-2023)20,000Market Cap (Jul-30-2023)0.138 Billion USDWorld Rank (Dec-25-2022)21,267Market Cap (Dec-25-2022)0.107 Billion USDWorld Rank (Jan-07-2022)21,111Annual Net Income in USD-43 Million USDAnnual Results for Period EndingFor year ending December-2025Company ProfileTrevi Therapeutics is a clinical-stage biopharmaceutical company that is developing the investigational therapy Haduvio™ to treat serious chronic cough conditions by targeting the central and peripheral nervous systems. Headquarters is in USA.
Company Website